Dural vasodilation causes a sensitization of rat caudal trigeminal neurones in vivo that is blocked by a 5-HT(1B/1D) agonist

British Journal of Pharmacology

Volumn 126, Issue 6, 1999, Pages 1478-1486

  Cumberbatch, M J ^a   Williamson, D J ^a   Mason, G S ^a   Hill, R G ^a   Hargreaves, R J ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

5HT(1B 1D) receptors; Central sensitization; Dura mater; Electrophysiology; Migraine; Trigeminal nucleus caudalis

Indexed keywords

3 [2 (DIMETHYLAMINO)ETHYL] 5 (1,2,4 TRIAZOL 1 YL)INDOLE; ALPHA CALCITONIN GENE RELATED PEPTIDE; SEROTONIN 1B AGONIST; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DURA MATER; INTRAVENOUS DRUG ADMINISTRATION; MALE; MENINGEAL ARTERY; NERVE STIMULATION; NOCICEPTIVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; TRIGEMINAL NUCLEUS; VASODILATATION; VIBRISSA;

EID: 0033031216     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702444     Document Type: Article

References (32)

1. BURSTEIN, R., YAMAMURA, H., MALICK, A. & STRASSMAN, A.M. (1998). Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol., 79, 964-82.
2. BUZZI, M.G., BONAMINI, M. & MOSKOWITZ, M.A. (1995). Neurogenic model of migraine. Cephalalgia, 15, 277-280.
3. COFFEY, R.J. & RHOTON, A.L. (1993). Pain-sensitive cranial structures. In Woolfs Headache. ed. Dalessio, D.J. & Silberstein, S.D. pp.19-41. Oxford University Press.
4. CUMBERBATCH, M.J., HEFTI, F.F., HILL, R.G. & HARGREAVES, R.J. (1997a). Drug-induced modulation of dural nociceptive neurotransmission. Proc. Soc. Neurosci., 27, 601.17.
5. CUMBERBATCH, M.J., HILL, R.G. & HARGREAVES, R.J. (1997b). Differential effects of naratriptan on spinal vs. trigeminal nociceptive responses. Cephalalgia, 17, 381.
6. CUMBERBATCH, M.J.. HILL, R.G. & HARGREAVES, R.J. (1997c). Rizatriptan has central antinociceptive effects against durally evoked responses. Eur. J. Pharmacol., 328, 37-40.
7. 1B/1D agonist. J. Physiol, 504P, 103P 104P.
8. DALESSIO, D.J. & SILBERSTEIN, S.D. (1993). Diagnosis and classification of headache. In Wolffs Headache. eds. Dalessio, D.J. & Silberstein, S.D. pp. 3-18. Oxford University Press.
9. DAO. T.T., LUND, J.P., REMILLARD, G. & LAVIGNE, G.J. (1995). Is myofascial pain of the temporal muscles relieved by oral sumatriptan? A cross-over pilot study. Pain, 62, 241-244.
10. DAVIS, K.D. & DOSTROVSKY, J.O. (1986). Activation of trigeminal brain-stem nociceptive neurons by dural artery stimulation. Pain, 25, 395-401.
11. FRIBERG, L., OLESEN, J., IVERSEN, H.K. & SPERLING, B. (1991). Migraine pain associated with middle cerebral artery dilation: reversal by sumatriptan. Lancet, 338 13-17.
12. GOADSBY, P.J. & HOSKIN, K.L. (1996). Inhibition of trigeminal neurones by intravenous administration of the serotonin (5-HT)l B/D receptor agonist zolmitriptan (31 IC90): are brain stem sites therapeutic target in migraine? Pain, 67, 355-359.
13. 1B1D) receptors. Br. J. Pharmacol., 122, 918-922.
14. HUMPHREY, P.P. & FENIUK, W. (1991). Mode of action of the antimigraine drug sumatriptan. Trends Pharmacol. Sci., 12, 444-446.
15. KAUBE, H., HOSKIN, K.L. & GOADSBY, P.J. (1992). Activation of the trigeminovascular system by mechanical distention of the superor sagittal sinus in the cat. Cephatalgia, 12, 133-136.
16. LONGMORE, J., SHAW, D., SMITH, D., HOPKINS, R., MCALLISTER, G., PICKARD, J.D., SIRINATHSINGHJI, D.J., BUTLER, A.J. & HILL, R.G. (1997). Differential distribution of 5-HTID- and 5-HTIB-immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new antimigraine drugs. Cephalalgia, 17, 833-842.
17. Mendell, L.M. (1966). Physiological properties of unmyelinated fiber projection to the spinal cord. Exp. Neurol. 16, 316-332.
18. MOSKOWITZ, M.A. (1992). Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol. Sci., 13, 307-311.
19. O'SHAUGHNESSY C., CONNOR, H.E. & FENIUK, W. (1993). Extracellular recordings of membrane potentials from guineapig isolated trigeminal ganglion: lack of effect of sumatriptan. Cephalalgia, 13, 175-179.
20. RAY, B.S. & WOLFF, H.G. (1940). Experimental studies on headache. Archives of Surgery, 41, 813-855.
21. ROBERTS-THOMSON, I., ARGYRIDES, J., PANNALL, P. & FREWIN, D. (1996). Sumatriptan and episodic pain syndromes other than migraine. Pain, 67, 226-227.
22. IB/1D receptor agonists on neurogenic dural plasma extravasation and vasodilation in anaesthetized rats. Neuropharmacology 36, 525-533.
23. SHEPHEARD, S.L., WILLIAMSON, D.J., WILLIAMS, J., HILL, R.G. & HARGREAVES, R.J. (1995). Comparison of the effects of sumatriptan and the NKI antagonist CP-99,994 on plasma extravasation in dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats. Neuropharmacol., 34, 255-261.
24. ID) receptors. Bioorgan. & Med. Chem. Lett., 6,1825-1830.
25. STRASSMAN, A., MASON, P., MOSKOWLTZ M. & MACIEWLCZ R. (1986). Response of brainstem trigeminal neurons to electrical stimulation of the dura. Brain Res., 379, 242-250.
26. THOMSEN, L.L., BRENNUM, J., IVERSEN, H.K. & OLESEN, J. (1996). Effect of a nitric oxide donor (glyeryl trinitrate) on nociceptive thresholds in man. Cephalalgia, 16, 169-174.
27. WILLIAMSON, D.J., CUMBERBATCH, M.J., SHEPHEARD, S.L. & HARGREAVES, R.J. (1998). Sensitization of caudal trigeminal neurones by dural artery dilation. Neurology, 50, A227.
28. WILLIAMSON, D.J., HARGREAVES, R.J., HILL, R.G. & SHEPHEARD, S.L. (1997a). Intravital microscope studies on the effects of neurokinin agonists and calcitonin gene-related peptide on dural vessel diameter in the anaesthetized rat. Cephalalgia, 17, 518-524.
29. WILLIAMSON, D.J., HARGREAVES, R.J., HILL, R.G. & SHEPHEARD, S.L. (1997b). Sumatriptan inhibits neurogenic vasodilation of dural blood vessels in the anaesthetized rat-intravital microscope studies. Cephalalgia, 17, 525-531.
30. WILLIAMSON, D.J., SHEPHEARD, S.L., HILL, R.G. & HARGREAVES, R.J. (1997c). The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation. Eur. J. Pharmacol., 328, 61-64.
31. WOOLF, C.J. (1983). Evidence for a central component of post-injury pain hypersensitivity. Nature, 306, 686-688.
32. WOOLF, C.J & KING, A.E. (1987). Physiology and morphology of multireceptive neurons with C-afferent fiber inputs in the deep dorsal horn of the rat lumbar spinal cord. J. Neurophysiol., 58, 460-479.